Group One Trading
CTXR icon

Group One Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Group One Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938 Buy
+1,551
New +$1.05K ﹤0.01% 7194
2025
Q3 		– Sell
-649
Closed -$1.03K – 8515
2025
Q2 		$1.03K Sell
649
-2,693
-81% -$2.47K ﹤0.01% 7553
2025
Q1 		$4.98K Sell
3,342
-1,475
-31% -$3.53K ﹤0.01% 6650
2024
Q4 		$19.3K Buy
4,817
+3,991
+483% +$26.9K ﹤0.01% 5711
2024
Q3 		$10.3K Sell
826
-128
-13% -$2.15K ﹤0.01% 5588
2024
Q2 		$13.9K Buy
954
+171
+22% +$3.06K ﹤0.01% 5453
2024
Q1 		$17.6K Sell
783
-241
-24% -$4.4K ﹤0.01% 5523
2023
Q4 		$19.4K Hold
1,024
– – ﹤0.01% 5771
2023
Q3 		$17.5K Buy
+1,024
New +$24.3K ﹤0.01% 5979
2023
Q2 		– Sell
-1,956
Closed -$64.4K – 7725
2023
Q1 		$57.2K Sell
1,956
-423
-18% -$12.2K ﹤0.01% 4751
2022
Q4 		$47K Buy
2,379
+652
+38% +$17.8K ﹤0.01% 5043
2022
Q3 		$52K Buy
+1,727
New +$47.5K ﹤0.01% 5377

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

Group One Trading's CTXR Position: Q2 2026 in Review

Group One Trading opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 1,551 shares worth $938. The stake represents ﹤0.01% of the portfolio and ranks #7194 among its holdings. This is a return to the name: Group One Trading previously reported a position in CTXR as recently as Q2 2025.

Group One Trading first reported a position in CTXR in Q3 2022 and has held it in 12 quarters since. The position peaked at $57.2K in Q1 2023. 42 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Group One Trading held 1,551 shares of Citius Pharmaceuticals worth $938 as of Q2 2026.
  • Citius Pharmaceuticals was a new Group One Trading position in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7194 holding.
  • Group One Trading first reported a position in Citius Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
  • Group One Trading's Citius Pharmaceuticals position peaked at $57.2K in Q1 2023.
  • 42 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.